| Original language | English (US) |
|---|---|
| Pages (from-to) | 691-696 |
| Number of pages | 6 |
| Journal | American Journal of Kidney Diseases |
| Volume | 80 |
| Issue number | 6 |
| DOIs |
|
| State | Published - Dec 2022 |
| Externally published | Yes |
ASJC Scopus subject areas
- Nephrology
Access to Document
Other files and links
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
In: American Journal of Kidney Diseases, Vol. 80, No. 6, 12.2022, p. 691-696.
Research output: Contribution to journal › Comment/debate › peer-review
}
TY - JOUR
T1 - An Endorsement of the Removal of Race From GFR Estimation Equations
T2 - A Position Statement From the National Kidney Foundation Kidney Disease Outcomes Quality Initiative
AU - National Kidney Foundation Kidney Disease Outcomes Quality Initiative
AU - Kramer, Holly J.
AU - Jaar, Bernard G.
AU - Choi, Michael J.
AU - Palevsky, Paul M.
AU - Vassalotti, Joseph A.
AU - Rocco, Michael V.
N1 - Funding Information: This work received support from the National Kidney Foundation . Funding Information: Holly J. Kramer, MD, MPH, Bernard G. Jaar, MD, MPH, Michael J. Choi, MD, Paul M. Palevsky, MD, Joseph A. Vassalotti, MD, and Michael V. Rocco, MD, MSCE. This work received support from the National Kidney Foundation. Dr Kramer reports serving as a consultant for Astra Zeneca and Bayer Pharmaceuticals and is AJKD Engagement Editor. Dr Choi reports receipt of an honorarium from InMed. Dr Palevsky reports serving as a consultant for Janssen Research & Development and is the current President of the NKF. Dr Vassalotti is chief medical officer of the NKF and serves as a consultant for Renalytix, plc. Drs Jaar and Rocco declare that they have no relevant financial interests. Dr Kramer is KDOQI Vice Chair of Commentaries, is on the editorial boards of the Journal of Renal Nutrition and Advances in Chronic Kidney Disease, and served as NKF immediate past-president. Dr Jaar is KDOQI Vice Chair of Education. Dr Choi is KDOQI Vice Chair of Policy. Dr Rocco is KDOQI Chair. Received August 2, 2022, following review and approval by the NKF Scientific Advisory Board (membership listed at https://www.kidney.org/about/sab). Accepted August 8, 2022, after editorial review by a Deputy Editor.
PY - 2022/12
Y1 - 2022/12
UR - http://www.scopus.com/inward/record.url?scp=85140617053&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85140617053&partnerID=8YFLogxK
U2 - 10.1053/j.ajkd.2022.08.004
DO - 10.1053/j.ajkd.2022.08.004
M3 - Comment/debate
C2 - 36058427
AN - SCOPUS:85140617053
SN - 0272-6386
VL - 80
SP - 691
EP - 696
JO - American Journal of Kidney Diseases
JF - American Journal of Kidney Diseases
IS - 6
ER -